摘要:
Methods and devices for treating tinnitus in human or animal subjects wherein the subject is caused to perceive a tinnitus suppressing sound which fully or partially suppresses the subject's tinnitus. In some embodiments of this method, the subject selects a sound that he or she perceives to be the same as the tinnitus and that sound (or a similar sound that is complementary to the subject's perceived tinnitus) is then used as the tinnitus suppressing sound. In other embodiments, the tinnitus suppressing may be a sound that has previously been determined to suppress tinnitus in a substantial number of subjects.
摘要:
Methods and devices for treating tinnitus in human or animal subjects wherein the subject is caused to perceive a tinnitus suppressing sound which fully or partially suppresses the subject's tinnitus. In some embodiments of this method, the subject selects a sound that he or she perceives to be the same as the tinnitus and that sound (or a similar sound that is complementary to the subject's perceived tinnitus) is then used as the tinnitus suppressing sound. In other embodiments, the tinnitus suppressing may be a sound that has previously been determined to suppress tinnitus in a substantial number of subjects.
摘要:
The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt thereof. These compounds inhibit serine protease, particularly the hepatitis C virus NS3-NS4A protease.
摘要:
The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt thereof. These compounds inhibit serine protease, particularly the hepatitis C virus NS3-NS4A protease.
摘要:
The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
摘要:
The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
摘要:
Described herein are compounds that are useful as protein kinase inhibitors having the formula: where R1-4, Q, and T are described in the specification. The compounds are useful for treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.
摘要:
An automatic vehicle following system is provided for controlling a following vehicle to maintain at least a predetermined distance behind a preceding vehicle and to substantially follow the path of the preceding vehicle. An on-line measurement system of the preceding vehicle generates signals indicative of the velocity (having speed and directional components) of the preceding vehicle, and a communication system transmits the velocity signals to the following vehicle. The following vehicle likewise has a communication system for receiving the signals from the preceding vehicle, and an on-line measurement system for providing signals indicative of the velocity of the following vehicle and signals indicative of the distance between the two vehicles. A signal processing system of the following vehicle is coupled to the communication system and on-line measurement system for estimating motion trajectory of the preceding vehicle based on the difference in the velocities of the preceding and following vehicles and the following distance. A control system generates control signals and takes action so as to perform speed control and maintain at least a predetermined safe following distance between the two vehicles, and steering control to substantially follow the path of the preceding vehicle.
摘要:
There discloses a ubiquitous energy network for optimum utilization of energy, which includes nodes connected by an interconnected network architecture of virtual pipelines transferring a ubiquitous energy flow, with the ubiquitous energy flow being transferred among the nodes bi-directionally. The node includes a system energy efficiency controller, and at least one of other nodes, an energy generation device, an energy storage device, an energy utilization device, and an energy regeneration device connected to the controller. The controller controls the input and output of the ubiquitous energy flow of the at least one of the other nodes, the energy generation device, the energy storage device, the energy utilization device, the energy regeneration device. Furthermore, the node, an access terminal, a virtual tag, and the virtual pipeline of the ubiquitous energy network, and a server and method for providing energy transaction and service by the ubiquitous energy network are disclosed.
摘要:
There discloses a ubiquitous energy network for optimum utilization of energy, which includes nodes connected by an interconnected network architecture of virtual pipelines transferring a ubiquitous energy flow, with the ubiquitous energy flow being transferred among the nodes bi-directionally. The node includes a system energy efficiency controller, and at least one of other nodes, an energy generation device, an energy storage device, an energy utilization device, and an energy regeneration device connected to the controller. The controller controls the input and output of the ubiquitous energy flow of the at least one of the other nodes, the energy generation device, the energy storage device, the energy utilization device, the energy regeneration device. Furthermore, the node, an access terminal, a virtual tag, and the virtual pipeline of the ubiquitous energy network, and a server and method for providing energy transaction and service by the ubiquitous energy network are disclosed.